Literature DB >> 376137

Randomized study of chemoimmunotherapy for advanced ovarian carcinoma: a preliminary report of a Southwest Oncology Group study.

D S Alberts, T E Moon, R A Stephens, H Wilson, N Oishi, R D Hilgers, R O'Toole, J T Thigpen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 376137

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

1.  Victor Bonney Lecture, 1980. Ovarian cancer--a gynaecological disorder?

Authors:  C N Hudson
Journal:  Ann R Coll Surg Engl       Date:  1981-03       Impact factor: 1.891

Review 2.  Update in cancer chemotherapy: genitourinary tract cancer, Part 5: Ovarian cancer.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1988-05       Impact factor: 1.798

3.  Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432.

Authors:  Y Nio; J Zighelboim; J S Berek; B Bonavida
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer. A randomized clinical study.

Authors:  G Bolis; G Bortolozzi; G Carinelli; M D'Incalci; F Gramellini; L Morasca; C Mangioni
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.